Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theoretical source of the Omicron variant

<< Previous

Bullboard Posts

Next >>

Comment by langostaon Jan 09, 2022 11:01am

463 Views

Post# 34297495

RE:RE:RE:Theoretical source of the Omicron variant

I have enjoyed Dr Campbell's presentations for some time, especially his Broccoli soup recipe. :-)

I do take vitamen D and believe in its efficacy.

Below is an extremely long Wiki presentation which covers most aspects of Covid misinformation most folks will probably find it too long and boring to completely consume, besides it does tend to jar the beliefs of some people.

https://en.wikipedia.org/wiki/COVID-19_misinformation#Vitamin_D

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment